| 000 | 01224 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250517195245.0 | ||
| 264 | 0 | _c20190319 | |
| 008 | 201903s 0 0 eng d | ||
| 022 | _a1540-336X | ||
| 024 | 7 |
_a10.1097/PPO.0000000000000301 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCottrell, Tricia R | |
| 245 | 0 | 0 |
_aPD-L1 and Emerging Biomarkers in Immune Checkpoint Blockade Therapy. _h[electronic resource] |
| 260 |
_bCancer journal (Sudbury, Mass.) _c |
||
| 300 |
_a41-46 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphocytes, Tumor-Infiltrating _xdrug effects |
| 650 | 0 | 4 |
_aMutation _xdrug effects |
| 650 | 0 | 4 |
_aNeoplasms _xgenetics |
| 650 | 0 | 4 |
_aProgrammed Cell Death 1 Receptor _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aTumor Burden _xdrug effects |
| 650 | 0 | 4 |
_aTumor Microenvironment _xdrug effects |
| 700 | 1 | _aTaube, Janis M | |
| 773 | 0 |
_tCancer journal (Sudbury, Mass.) _gvol. 24 _gno. 1 _gp. 41-46 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/PPO.0000000000000301 _zAvailable from publisher's website |
| 999 |
_c28005996 _d28005996 |
||